Vitamin D-3 regulation of stromelysin-1 (MMP-3) in chondrocyte cultures is mediated by protein kinase C

被引:0
|
作者
Schmitz, JP
Schwartz, Z
Sylvia, VL
Dean, DD
Calderon, F
Boyan, BD
机构
[1] UNIV TEXAS, HLTH SCI CTR, DEPT ORTHOPAED, SAN ANTONIO, TX 78284 USA
[2] UNIV TEXAS, HLTH SCI CTR, DEPT ORAL & MAXILLOFACIAL SURG, SAN ANTONIO, TX 78284 USA
[3] UNIV TEXAS, HLTH SCI CTR, DEPT BIOCHEM, SAN ANTONIO, TX 78284 USA
[4] UNIV TEXAS, HLTH SCI CTR, DEPT PERIODONT, SAN ANTONIO, TX 78284 USA
[5] HEBREW UNIV JERUSALEM, HADASSAH FAC DENT MED, IL-91010 JERUSALEM, ISRAEL
关键词
D O I
10.1002/(SICI)1097-4652(199609)168:3<570::AID-JCP9>3.3.CO;2-S
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Matrix metalloproteinases (MMPs) are a group of enzymes with the potential to degrade extracellular matrix proteins. One of the MMPs, stromelysin-1 (MMP-3) has been localized to extracellular matrix vesicles in growth plate chondrocyte cultures, suggesting involvement of this enzyme in remodeling of the extracellular matrix during endochondral development, a process which is regulated by the vitamin D metabolites, 1,25-(OH)(2)D-3 and 24,25-(OH)(2)D-3. To determine whether stromelysin-1 is regulated by vitamin D as well, confluent cultures of cells derived from growth zone (GC) and resting zone (RC) rat costochondral cartilage were treated with 1 alpha,25-(OH)(2)D-3 (1,25) and 24R,25-(OH)(2)D-3 (24,25), respectively, and the effect on stromelysin-1 assessed by casein gel zymography and Western blots. Although stromelysin-1 activity was enriched in the matrix vesicle fraction, only the plasma membrane enzyme was affected by the treatment; 1,25 and 24,25 caused a marked decrease in plasma membrane stromelysin-1 activity in their target cells. Since plasma-membrane protein kinase C (PKC) activity is stimulated by 1,25 and 24,25, we hypothesized that stromelysin-1 activity was regulated by the vitamin D metabolites via PKC-dependent phosphorylation. To test this, membrane fractions (containing endogenous PKC alpha and zeta as well as stromelysin-1) were incubated in the presence of purified rat brain PKC and/or recombinant human (rh) stromelysin-1 and [gamma(32)P]-ATP and anti-stromelysin-1 immunoprecipitates were analyzed by autoradiography and Western blots. Immuno-phospho-stromelysin-1 was localized to a 52-kDa band in the plasma membrane fraction only; no phosphorylation was observed in the matrix vesicle fraction. Selective inhibitors of PKC activity demonstrated that phosphorylation was inhibited by H7 and low concentrations of H8, but not by HA1004, indicating that PKC, not PKA, was responsible. Protein phosphatase 2A(1) (PP2A), a serine/threonine-specific phosphatase, selectively removed the radiolabel in a time-dependent manner, providing further support for a PKC-dependent phosphorylation mechanism. Incubation of resting zone cell plasma membranes with 24,25, but not 1,25, resulted in phosphorylation of stromelysin-1, demonstrating that the nongenomic effect was metabolite-specific. This suggests that this may be one mechanism by which vitamin D metabolites regulate stromelysin-1 activity and that PKC-dependent phosphorylation inhibits the metalloproteinase. (C) 1996 Wiley-Liss, Inc.
引用
收藏
页码:570 / 579
页数:10
相关论文
共 50 条
  • [21] Stromelysin-1 (MMP-3) and stromelysin-2 (MMP-10) expression in developing human bone: Potential roles in skeletal development
    Bord, S
    Horner, A
    Hembry, RM
    Compston, JE
    BONE, 1998, 23 (01) : 7 - 12
  • [22] MATURATION-DEPENDENT REGULATION OF PROTEIN-KINASE-C ACTIVITY BY VITAMIN-D(3) METABOLITES IN CHONDROCYTE CULTURES
    SYLVIA, VL
    SCHWARTZ, Z
    SCHUMAN, L
    MORGAN, RT
    MACKEY, S
    GOMEZ, R
    BOYAN, BD
    JOURNAL OF CELLULAR PHYSIOLOGY, 1993, 157 (02) : 271 - 278
  • [23] Novel specific human and mouse stromelysin-1 (MMP-3) and stromelysin-2 (MMP-10) antibodies for biochemical and immunohistochemical analyses
    Mirastschijski, Ursula
    Dinesh, Nilima
    Baskaran, Sudarson
    Wedekind, Dirk
    Gavrilovic, Jelena
    Murray, Megan Y.
    Bevan, Damon
    Kelm, Sorge
    WOUND REPAIR AND REGENERATION, 2019, 27 (04) : 309 - 323
  • [24] Novel highly potent, structurally simple γ-trifluoromethyl γ-sulfone hydroxamate inhibitor of stromelysin-1 (MMP-3)
    Sani, M
    Candiani, G
    Pecker, F
    Malpezzi, L
    Zanda, M
    TETRAHEDRON LETTERS, 2005, 46 (14) : 2393 - 2396
  • [25] Differences in susceptibility of MBP charge isomers to digestion by stromelysin-1 (MMP-3) and release of an immunodominant epitope
    D'Souza, Cheryl A.
    Moscarello, Mario A.
    NEUROCHEMICAL RESEARCH, 2006, 31 (08) : 1045 - 1054
  • [26] Differences in Susceptibility of MBP Charge Isomers to Digestion by Stromelysin-1 (MMP-3) and Release of an Immunodominant Epitope
    Cheryl A. D’Souza
    Mario A. Moscarello
    Neurochemical Research, 2006, 31 : 1045 - 1054
  • [27] Stromelysin-1 (MMP-3) is inducible in T lymphoma cells and accelerates the growth of lymphoid tumors in vivo
    Van Themsche, C
    Potworowski, ÉF
    St-Pierre, Y
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2004, 315 (04) : 884 - 891
  • [28] Adenovirus-mediated gene therapy carrying MMP3 (stromelysin-1)
    Yoon, SK
    Nam, SW
    Cho, SH
    Yang, JM
    Han, NI
    Choi, SW
    Ahn, BM
    Lee, YS
    Lee, CD
    Chung, KW
    Sun, HS
    JOURNAL OF HEPATOLOGY, 2005, 42 : 124 - 124
  • [29] Persistence of atherosclerotic plaque but reduced aneurysm formation in mice with stromelysin-1 (MMP-3) gene inactivation
    Silence, J
    Lupu, F
    Collen, D
    Lijnen, HR
    ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2001, 21 (09) : 1440 - 1445
  • [30] A quantum mechanical approach to ligand binding - Calculation of ligand-protein binding affinities for stromelysin-1 (MMP-3) inhibitors
    Li, Jian
    Reynolds, Charles. H.
    CANADIAN JOURNAL OF CHEMISTRY-REVUE CANADIENNE DE CHIMIE, 2009, 87 (10): : 1480 - 1484